These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35111615)

  • 1. Computed tomography (CT) and magnetic resonance imaging (MRI) of diffuse liver disease: a multiparametric predictive modelling algorithm can aid categorization of liver parenchyma.
    Donners R; Zaugg C; Gehweiler JE; Boldanova T; Heim MH; Terracciano LM; Boll DT
    Quant Imaging Med Surg; 2022 Feb; 12(2):1186-1197. PubMed ID: 35111615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.
    Pavlides M; Banerjee R; Tunnicliffe EM; Kelly C; Collier J; Wang LM; Fleming KA; Cobbold JF; Robson MD; Neubauer S; Barnes E
    Liver Int; 2017 Jul; 37(7):1065-1073. PubMed ID: 27778429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study.
    Kudo M; Zheng RQ; Kim SR; Okabe Y; Osaki Y; Iijima H; Itani T; Kasugai H; Kanematsu M; Ito K; Usuki N; Shimamatsu K; Kage M; Kojiro M
    Intervirology; 2008; 51 Suppl 1():17-26. PubMed ID: 18544944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
    Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
    Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI.
    Yang M; Zhang Y; Zhao W; Cheng W; Wang H; Guo S
    BMC Med Imaging; 2020 Oct; 20(1):119. PubMed ID: 33081713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1204 Healthy Adults Using Unenhanced CT as a Reference Standard.
    Pickhardt PJ; Blake GM; Graffy PM; Sandfort V; Elton DC; Perez AA; Summers RM
    AJR Am J Roentgenol; 2021 Aug; 217(2):359-367. PubMed ID: 32936018
    [No Abstract]   [Full Text] [Related]  

  • 7. Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI.
    Min JH; Kang TW; Kim YY; Cha DI; Kim YK; Kim SH; Sinn DH; Ha SY; Kim K
    Eur Radiol; 2021 May; 31(5):3315-3325. PubMed ID: 33159576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
    Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
    Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
    World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
    Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
    JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis--a multiparametric approach.
    Feier D; Balassy C; Bastati N; Fragner R; Wrba F; Ba-Ssalamah A
    Eur Radiol; 2016 Feb; 26(2):539-46. PubMed ID: 25991488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unenhanced computed tomography for non-invasive diagnosis of hepatic steatosis with low tube potential protocol.
    Choi Y; Kim DK; Youn SY; Kim H; Choi JI
    Quant Imaging Med Surg; 2022 Feb; 12(2):1348-1358. PubMed ID: 35111629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
    Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
    Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.
    Imajo K; Tetlow L; Dennis A; Shumbayawonda E; Mouchti S; Kendall TJ; Fryer E; Yamanaka S; Honda Y; Kessoku T; Ogawa Y; Yoneda M; Saito S; Kelly C; Kelly MD; Banerjee R; Nakajima A
    World J Gastroenterol; 2021 Feb; 27(7):609-623. PubMed ID: 33642832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different enhancement of the hepatic parenchyma in dynamic CT for patients with normal liver and chronic liver diseases and with the dose of contrast medium based on body surface area.
    Koiwahara G; Tsuda T; Matsuda M; Hirata M; Tanaka H; Hyodo T; Kido T; Mochizuki T
    Jpn J Radiol; 2015 Apr; 33(4):194-200. PubMed ID: 25673431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT.
    Boyce CJ; Pickhardt PJ; Kim DH; Taylor AJ; Winter TC; Bruce RJ; Lindstrom MJ; Hinshaw JL
    AJR Am J Roentgenol; 2010 Mar; 194(3):623-8. PubMed ID: 20173137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hepatic steatosis on contrast-enhanced CT images: diagnostic accuracy of identification of areas of presumed focal fatty sparing.
    Lawrence DA; Oliva IB; Israel GM
    AJR Am J Roentgenol; 2012 Jul; 199(1):44-7. PubMed ID: 22733892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease.
    Kim JW; Lee YS; Park YS; Kim BH; Lee SY; Yeon JE; Lee CH
    Sci Rep; 2020 Feb; 10(1):2671. PubMed ID: 32060386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.